Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Enprovin Plus
- Development stage
- Unknown
- Lead developer
- Navana Pharmaceuticals
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Enprovin Plus is a veterinary feed supplement and water-soluble powder developed by Navana Pharmaceuticals for poultry. It is formulated to support and improve intestinal health, enhance immunity, and optimize feed conversion ratio (FCR) in birds. The product contains a comprehensive blend of vitamins (including Vitamin A, Vitamin D3, Vitamin E, Vitamin K3, Riboflavin, Niacin, Calcium D-Pantothenate, and Pyridoxine), Methyl Sulphonyl Methane, prebiotics (Dextran Oligosaccharide), probiotics (Lactobacillus acidophilus, Bifidobacterium bifidum, and Saccharomyces boulardii), and enzymes derived from Aspergillus oryzae. It is primarily indicated for poor intestinal health, promoting digestion, and increasing meat and egg production in poultry.
- Brand names
- Enprovin Plus
Beyond the preview
Go deeper on Enprovin Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Enprovin Plus.